Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study

Pre-clinical studies have suggested sex hormone signalling pathways may influence tumorigenesis in neuroendocrine neoplasia (NEN). We conducted a retrospective, population-based study to compare overall survival (OS) between males and females with NEN. A total of 14,834 cases of NEN diagnosed betwee...

Full description

Bibliographic Details
Main Authors: Benjamin E. White, Beth Russell, Sebastiaan Remmers, Brian Rous, Kandiah Chandrakumaran, Kwok F. Wong, Mieke Van Hemelrijck, Rajaventhan Srirajaskanthan, John K. Ramage
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/6/1863
_version_ 1797612924924067840
author Benjamin E. White
Beth Russell
Sebastiaan Remmers
Brian Rous
Kandiah Chandrakumaran
Kwok F. Wong
Mieke Van Hemelrijck
Rajaventhan Srirajaskanthan
John K. Ramage
author_facet Benjamin E. White
Beth Russell
Sebastiaan Remmers
Brian Rous
Kandiah Chandrakumaran
Kwok F. Wong
Mieke Van Hemelrijck
Rajaventhan Srirajaskanthan
John K. Ramage
author_sort Benjamin E. White
collection DOAJ
description Pre-clinical studies have suggested sex hormone signalling pathways may influence tumorigenesis in neuroendocrine neoplasia (NEN). We conducted a retrospective, population-based study to compare overall survival (OS) between males and females with NEN. A total of 14,834 cases of NEN diagnosed between 2012 and 2018, recorded in England’s National Cancer Registry and Analysis Service (NCRAS), were analysed. The primary outcome was OS with 5 years maximum follow-up. Multivariable analysis, restricted mean survival time and mediation analysis were performed. Appendiceal, pulmonary and early-stage NEN were most commonly diagnosed in females; stomach, pancreatic, small intestinal, colonic, rectal and later-stage NEN were more often diagnosed in males. Females displayed increased survival irrespective of the stage, morphology or level of deprivation. On average, they survived 3.62 (95% CI 1.73–5.90) to 10.26 (6.6–14.45) months longer than males; this was statistically significant in NEN of the lung, pancreas, rectum and stomach (<i>p</i> < 0.001). The stage mediated improved survival in stomach, lung, and pancreatic NEN but not in rectal NEN. The reasons underlying these differences are not yet understood. Overall, females diagnosed with NEN tend to survive longer than males, and the stage at presentation only partially explains this. Future research, as well as prognostication and treatment, should consider sex as an important factor.
first_indexed 2024-03-11T06:48:44Z
format Article
id doaj.art-8af31fbfe83749dabc5ee596a8d0bcad
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T06:48:44Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-8af31fbfe83749dabc5ee596a8d0bcad2023-11-17T10:08:15ZengMDPI AGCancers2072-66942023-03-01156186310.3390/cancers15061863Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based StudyBenjamin E. White0Beth Russell1Sebastiaan Remmers2Brian Rous3Kandiah Chandrakumaran4Kwok F. Wong5Mieke Van Hemelrijck6Rajaventhan Srirajaskanthan7John K. Ramage8Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke RG24 9NA, UKTranslational Oncology and Urology Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London WC2R 2LS, UKDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, 3015 GD Rotterdam, The NetherlandsNHS Digital, 7 and 8 Wellington Place, Leeds LS1 4AP, UKBasingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke RG24 9NA, UKNHS Digital, 7 and 8 Wellington Place, Leeds LS1 4AP, UKTranslational Oncology and Urology Research, School of Cancer & Pharmaceutical Sciences, King’s College London, London WC2R 2LS, UKKing’s Health Partners ENETS Centre of Excellence, King’s College Hospital, London SE5 9RS, UKBasingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke RG24 9NA, UKPre-clinical studies have suggested sex hormone signalling pathways may influence tumorigenesis in neuroendocrine neoplasia (NEN). We conducted a retrospective, population-based study to compare overall survival (OS) between males and females with NEN. A total of 14,834 cases of NEN diagnosed between 2012 and 2018, recorded in England’s National Cancer Registry and Analysis Service (NCRAS), were analysed. The primary outcome was OS with 5 years maximum follow-up. Multivariable analysis, restricted mean survival time and mediation analysis were performed. Appendiceal, pulmonary and early-stage NEN were most commonly diagnosed in females; stomach, pancreatic, small intestinal, colonic, rectal and later-stage NEN were more often diagnosed in males. Females displayed increased survival irrespective of the stage, morphology or level of deprivation. On average, they survived 3.62 (95% CI 1.73–5.90) to 10.26 (6.6–14.45) months longer than males; this was statistically significant in NEN of the lung, pancreas, rectum and stomach (<i>p</i> < 0.001). The stage mediated improved survival in stomach, lung, and pancreatic NEN but not in rectal NEN. The reasons underlying these differences are not yet understood. Overall, females diagnosed with NEN tend to survive longer than males, and the stage at presentation only partially explains this. Future research, as well as prognostication and treatment, should consider sex as an important factor.https://www.mdpi.com/2072-6694/15/6/1863neuroendocrine tumourneuroendocrine tumourneuroendocrine neoplasiacarcinoidepidemiologysurvival
spellingShingle Benjamin E. White
Beth Russell
Sebastiaan Remmers
Brian Rous
Kandiah Chandrakumaran
Kwok F. Wong
Mieke Van Hemelrijck
Rajaventhan Srirajaskanthan
John K. Ramage
Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
Cancers
neuroendocrine tumour
neuroendocrine tumour
neuroendocrine neoplasia
carcinoid
epidemiology
survival
title Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
title_full Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
title_fullStr Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
title_full_unstemmed Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
title_short Sex Differences in Survival from Neuroendocrine Neoplasia in England 2012–2018: A Retrospective, Population-Based Study
title_sort sex differences in survival from neuroendocrine neoplasia in england 2012 2018 a retrospective population based study
topic neuroendocrine tumour
neuroendocrine tumour
neuroendocrine neoplasia
carcinoid
epidemiology
survival
url https://www.mdpi.com/2072-6694/15/6/1863
work_keys_str_mv AT benjaminewhite sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT bethrussell sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT sebastiaanremmers sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT brianrous sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT kandiahchandrakumaran sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT kwokfwong sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT miekevanhemelrijck sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT rajaventhansrirajaskanthan sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy
AT johnkramage sexdifferencesinsurvivalfromneuroendocrineneoplasiainengland20122018aretrospectivepopulationbasedstudy